➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Johnson and Johnson
Dow
Mallinckrodt
AstraZeneca

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

ACTICLATE CAP Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Acticlate Cap patents expire, and what generic alternatives are available?

Acticlate Cap is a drug marketed by Almirall and is included in one NDA.

The generic ingredient in ACTICLATE CAP is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

US ANDA Litigation and Generic Entry Outlook for Acticlate Cap

A generic version of ACTICLATE CAP was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.

  Start Trial

Summary for ACTICLATE CAP
Drug patent expirations by year for ACTICLATE CAP
Pharmacology for ACTICLATE CAP

US Patents and Regulatory Information for ACTICLATE CAP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almirall ACTICLATE CAP doxycycline hyclate CAPSULE;ORAL 208253-001 Apr 26, 2016 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
Merck
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.